Phospholamban is concentrated in the nuclear envelope of cardiomyocytes and involved in perinuclear/nuclear calcium handling

Journal of Molecular and Cellular Cardiology

Volumn 100, Issue , 2016, Pages 1-8

  Wu, Adonis Z ^a,b   Xu, Dongzhu ^a,c   Yang, Na ^a,d   Lin, Shien Fong ^a,b   Chen, Peng Sheng ^a   Cala, Steven E ^e   Chen, Zhenhui ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium signaling; Cardiomyocyte; Nuclear membranes; Perinuclear Ca2 + dynamics; Phospholamban; Sarcoplasmic reticulum Ca2 + ATPase

Indexed keywords

ISOPRENALINE; PHOSPHOLAMBAN; SAPONIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; CALCIUM; CALCIUM BINDING PROTEIN;

ADULT; ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CALCIUM SIGNALING; CALCIUM TRANSPORT; CARDIAC MUSCLE CELL; CELL NUCLEUS MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; ANIMAL; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; HUMAN; INTRACELLULAR SPACE; METABOLISM; MOLECULAR IMAGING; NUCLEOLUS; RABBITS AND HARES; SPECIES DIFFERENCE; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM; CALCIUM SIGNALING; CALCIUM-BINDING PROTEINS; CELL NUCLEOLUS; HUMANS; INTRACELLULAR SPACE; ISOPROTERENOL; MICE; MICROSCOPY, FLUORESCENCE; MOLECULAR IMAGING; MYOCYTES, CARDIAC; NUCLEAR ENVELOPE; RABBITS; SPECIES SPECIFICITY;

EID: 84988963286     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2016.09.008     Document Type: Article

References (40)

1. [1] Simmerman, H.K., Jones, L.R., Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol. Rev. 78 (1998), 921–947.
2. [2] MacLennan, D.H., Kranias, E.G., Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 4 (2003), 566–577.
3. [3] Kranias, E.G., Hajjar, R.J., Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome. Circ. Res. 110 (2012), 1646–1660.
4. 2 +-ATPase activity in guinea pig ventricles. J. Biol. Chem. 258 (1983), 464–471.
5. [5] Bers, D.M., Cardiac excitation-contraction coupling. Nature 415 (2002), 198–205.
6. [6] Eisner, D., Bode, E., Venetucci, L., Trafford, A., Calcium flux balance in the heart. J. Mol. Cell. Cardiol. 58 (2013), 110–117.
7. 2 + uptake in mammalian ventricular myocytes. Am. J. Phys. 261 (1991), H1344–H1349.
8. [8] Santana, L.F., Kranias, E.G., Lederer, W.J., Calcium sparks and excitation-contraction coupling in phospholamban-deficient mouse ventricular myocytes. J. Physiol. 503:Pt 1 (1997), 21–29.
9. 2 + waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice. Circ. Res. 113 (2013), 517–526.
10. [10] Chan, Y.H., Tsai, W.C., Song, Z., Ko, C.Y., Qu, Z., Weiss, J.N., et al. Acute reversal of phospholamban inhibition facilitates the rhythmic whole-cell propagating calcium waves in isolated ventricular myocytes. J. Mol. Cell. Cardiol. 80C (2015), 126–135.
11. 2 + store. Science 270 (1995), 1835–1838.
12. [12] Hardingham, G.E., Chawla, S., Johnson, C.M., Bading, H., Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 385 (1997), 260–265.
13. 2 + signalling. Cell Calcium 49 (2011), 280–289.
14. 2 + store throughout cardiac myocyte. Circ. Res. 99 (2006), 283–291.
15. 2 + signaling in cardiac myocyte excitation-transcription coupling. J. Clin. Invest. 116 (2006), 675–682.
16. 2 + signaling during the development of hypertrophy and heart failure. Circulation 130 (2014), 244–255.
17. 2 + sparks and waves mediated by inositol 1,4,5-trisphosphate receptors in neonatal rat cardiomyocytes. Cell Calcium 43 (2008), 165–174.
18. [18] Bare, D.J., Kettlun, C.S., Liang, M., Bers, D.M., Mignery, G.A., Cardiac type 2 inositol 1,4,5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase II. J. Biol. Chem. 280 (2005), 15912–15920.
19. 2 + from the nuclear envelope. Cell 80 (1995), 439–444.
20. [20] Humbert, J.P., Matter, N., Artault, J.C., Koppler, P., Malviya, A.N., Inositol 1,4,5-trisphosphate receptor is located to the inner nuclear membrane vindicating regulation of nuclear calcium signaling by inositol 1,4,5-trisphosphate. Discrete distribution of inositol phosphate receptors to inner and outer nuclear membranes. J. Biol. Chem. 271 (1996), 478–485.
21. 2 + signalling in the mammalian heart. J. Physiol. 584 (2007), 601–611.
22. 2 + signalling in cat atrial excitation-contraction coupling and arrhythmias. J. Physiol. 555 (2004), 607–615.
23. 2 + release. J. Biol. Chem. 287 (2012), 16670–16680.
24. [24] Escobar, M., Cardenas, C., Colavita, K., Petrenko, N.B., Franzini-Armstrong, C., Structural evidence for perinuclear calcium microdomains in cardiac myocytes. J. Mol. Cell. Cardiol. 50 (2011), 451–459.
25. [25] Jorgensen, A.O., Jones, L.R., Immunoelectron microscopical localization of phospholamban in adult canine ventricular muscle. J. Cell Biol. 104 (1987), 1343–1352.
26. [26] Sleiman, N.H., McFarland, T.P., Jones, L.R., Cala, S.E., Transitions of protein traffic from cardiac ER to junctional SR. J. Mol. Cell. Cardiol. 81C (2015), 34–45.
27. [27] Ferguson, D.G., Young, E.F., Raeymaekers, L., Kranias, E.G., Localization of phospholamban in smooth muscle using immunogold electron microscopy. J. Cell Biol. 107 (1988), 555–562.
28. [28] Tadevosyan, A., Allen, B.G., Nattel, S., Isolation and study of cardiac nuclei from canine myocardium and adult ventricular myocytes. Methods Mol. Biol. 1234 (2015), 69–80.
29. 2 +-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12. J. Biol. Chem. 282 (2007), 20968–20976.
30. [30] Chen, Z., Competitive displacement of wild-type phospholamban from the Ca-free cardiac calcium pump by phospholamban mutants with different binding affinities. J. Mol. Cell. Cardiol. 76c (2014), 130–137.
31. [31] Fricker, M., Hollinshead, M., White, N., Vaux, D., Interphase nuclei of many mammalian cell types contain deep, dynamic, tubular membrane-bound invaginations of the nuclear envelope. J. Cell Biol. 136 (1997), 531–544.
32. [32] Haghighi, K., Kolokathis, F., Gramolini, A.O., Waggoner, J.R., Pater, L., Lynch, R.A., et al. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 1388–1393.
33. [33] Haghighi, K., Kolokathis, F., Pater, L., Lynch, R.A., Asahi, M., Gramolini, A.O., et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J. Clin. Invest. 111 (2003), 869–876.
34. [34] Schmitt, J.P., Kamisago, M., Asahi, M., Li, G.H., Ahmad, F., Mende, U., et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299 (2003), 1410–1413.
35. [35] Karakikes, I., Stillitano, F., Nonnenmacher, M., Tzimas, C., Sanoudou, D., Termglinchan, V., et al. Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy. Nat. Commun., 6, 2015, 6955.
36. [36] Haghighi, K., Pritchard, T., Bossuyt, J., Waggoner, J.R., Yuan, Q., Fan, G.C., et al. The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase. J. Mol. Cell. Cardiol. 52 (2012), 773–782.
37. [37] Haghighi, K., Schmidt, A.G., Hoit, B.D., Brittsan, A.G., Yatani, A., Lester, J.W., et al. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. J. Biol. Chem. 276 (2001), 24145–24152.
38. 2 +-dependent hypertrophic signaling. Am. J. Physiol. Heart Circ. Physiol. 302 (2012), H2574–H2582.
39. [39] Nakayama, H., Bodi, I., Maillet, M., DeSantiago, J., Domeier, T.L., Mikoshiba, K., et al. The IP3 receptor regulates cardiac hypertrophy in response to select stimuli. Circ. Res. 107 (2010), 659–666.
40. 2 + control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes?. Sci. Signal., 1, 2008, pe31.